Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices (HEMOCARD)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Grenoble, France
- UniversityHospitalGrenoble
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- more or equal than 18 years old
- patient affiliated to social security or similarly regime
- patient sent to hospital for cardiac surgery requiring ECC
Exclusion Criteria:
- Pregnant women and lactating mothers
- Ward of court or under guardianship
- Adult unable to express their consent
- Person deprived of freedom by judicial or administrative decision
- Person hospitalized without their consent
- Person under legal protection
- Person participating in another clinical study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: vacuum device - suction cup
|
the vacuum device is left on the 2 wounds (caused by the ECC cannulas) for 15 min (possible a second time of 15 min : 30 min max.)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Persistence or absence of bleeding extraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Time Frame: 20-30 min
|
20-30 min
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Persistence or absence of bleeding intraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Time Frame: 20-30 min
|
20-30 min
|
|
Persistence or absence of bleeding at the orifice of the retrograde cannulation when the vacuum was removed.
Time Frame: 20-30 min
|
20-30 min
|
|
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Time Frame: 20- 30 min
|
20- 30 min
|
|
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Time Frame: 20 -30 min
|
20 -30 min
|
|
Persistence or absence of bleeding at the orifice of the aortic purge when the vacuum was removed.
Time Frame: 20 -30 min
|
20 -30 min
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Dominique BLIN, MD, PhD, University Hospital, Grenoble
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DCIC 0809
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.